Siemens installs experimental FFDM
The first prototype of Siemens' new full-field digital mammography system has been installed at the University of California, Los Angeles, Iris Cantor Center for Breast Imaging. The experimental system, called Mammomat NovationDR, is built around an
The first prototype of Siemens' new full-field digital mammography system has been installed at the University of California, Los Angeles, Iris Cantor Center for Breast Imaging. The experimental system, called Mammomat NovationDR, is built around an amorphous selenium detector, which directly converts x-rays to digital signals. The 25 x 29-cm detector is large enough to image most breasts, according to the company. In clinical studies at the breast center, diagnostic content and image quality of digital images obtained using the NovationDR will be compared with those of analog images obtained with the same level of radiation exposure. Siemens expects to commercially release the new digital system outside the U.S. by the end of 2003. A U.S. launch will depend on FDA approval.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
